
    
      This is a Phase I, single-center, open-label, single dose study to evaluate the effect of
      food, gender, and age on the safety and Pharmacokinetic profiles of single doses of SUVN-911,
      administered orally in healthy subjects.

      The primary objective is to evaluate the effect of food, gender, and age on the
      pharmacokinetics of a single dose of SUVN-911 administered orally to healthy subjects.

      The secondary objective is to evaluate the safety and tolerability of a single dose of
      SUVN-911 administered orally to healthy adult male, female, and elderly subjects
    
  